ARGOS THERAPEUTICS INC Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ARGSQ and buy or sell other stocks, ETFs, and their options commission-free!About ARGSQ
Argos Therapeutics, Inc., a biotechnology company, engages in developing immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The company has clinical trial programs in cancer and human immunodeficiency virus.
CEOJeffrey D. Abbey, MBA
CEOJeffrey D. Abbey, MBA
Employees—
Employees—
HeadquartersDurham, North Carolina
HeadquartersDurham, North Carolina
Founded1997
Founded1997
Employees—
Employees—
ARGSQ Key Statistics
Market cap567.40K
Market cap567.40K
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume3.73K
Average volume3.73K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.25
52 Week high$0.25
52 Week low$0.019
52 Week low$0.019
Stock Snapshot
ARGOS THERAPEUTICS INC Common Stock(ARGSQ) stock is priced at $0.05, giving the company a market capitalization of 567.4K. It carries a P/E multiple of -0.03.
During the trading day, ARGOS THERAPEUTICS INC Common Stock(ARGSQ) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for ARGOS THERAPEUTICS INC Common Stock(ARGSQ) stock has reached 0, versus its average volume of 3.73K.
Over the past 52 weeks, ARGOS THERAPEUTICS INC Common Stock(ARGSQ) stock has traded between a high of $0.25 and a low of $0.02.
Over the past 52 weeks, ARGOS THERAPEUTICS INC Common Stock(ARGSQ) stock has traded between a high of $0.25 and a low of $0.02.